The Europe Research-grade Proteins Market would witness market growth of 15.0% CAGR during the forecast period (2023-2030).
The market for research-grade proteins is competitive and includes established and smaller biotechnology firms. Some well-known players in this industry include Thermo Fisher Scientific, Sigma-Aldrich (now part of MilliporeSigma), Abcam, Bio-Rad Laboratories, and Novus Biologicals. Many suppliers in this market offer customized solutions, allowing researchers to order proteins tailored to their specific research needs. Additionally, specialized companies may focus on particular classes of proteins or specific research areas. High-quality and highly pure proteins are critical for research accuracy and reproducibility.
These are distributed through various channels, including direct sales, distributors, and online marketplaces. Researchers can order these products directly from suppliers or through laboratory procurement systems. Suppliers in this market must adhere to regulatory standards and guidelines, mainly if they produce proteins for diagnostics or therapeutic applications. Compliance with good manufacturing practices and other relevant regulations is crucial.
Europe boasts a robust life sciences sector, with leading research institutions and universities conducting cutting-edge research in genomics, proteomics, drug discovery, and molecular biology. These research activities fuel the demand for research-grade proteins. Europe has a thriving pharmaceutical industry, with many companies involved in developing innovative drugs and biopharmaceuticals. Europe has seen the emergence of numerous biotech startups and entrepreneurial ventures focused on various aspects of the life sciences. Many of these startups require research-grade proteins for their research and development activities.
The Germany region dominated the Europe Research-grade Proteins Market, by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $163.7 Million by 2030. The UK market is exhibiting a CAGR of 14% during (2023 - 2030). Additionally, The France market would experience a CAGR of 15.8% during (2023 - 2030).
Based on Host Cell, the market is segmented into Mammalian Cells, Bacterial Cells, Yeast & Fungi, Insect Cells, and Others. Based on Product, the market is segmented into Cytokines & Growth Factors, Immune Checkpoint Proteins, Enzymes, Hormones, Antibodies, Virus Antigens, Recombinant Regulatory Proteins, and Others. Based on End-use, the market is segmented into Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., Abcam Plc, Miltenyi Biotech B.V. & Co. KG, Genscript Biotech Corporation, Bio-Techne Corporation, Proteintech Group, Inc., AcroBiosystems INC., Sino Biologicals, Inc. and ProSpec-Tany TechnoGene Ltd. and New England Biolabs, Inc.
The market for research-grade proteins is competitive and includes established and smaller biotechnology firms. Some well-known players in this industry include Thermo Fisher Scientific, Sigma-Aldrich (now part of MilliporeSigma), Abcam, Bio-Rad Laboratories, and Novus Biologicals. Many suppliers in this market offer customized solutions, allowing researchers to order proteins tailored to their specific research needs. Additionally, specialized companies may focus on particular classes of proteins or specific research areas. High-quality and highly pure proteins are critical for research accuracy and reproducibility.
These are distributed through various channels, including direct sales, distributors, and online marketplaces. Researchers can order these products directly from suppliers or through laboratory procurement systems. Suppliers in this market must adhere to regulatory standards and guidelines, mainly if they produce proteins for diagnostics or therapeutic applications. Compliance with good manufacturing practices and other relevant regulations is crucial.
Europe boasts a robust life sciences sector, with leading research institutions and universities conducting cutting-edge research in genomics, proteomics, drug discovery, and molecular biology. These research activities fuel the demand for research-grade proteins. Europe has a thriving pharmaceutical industry, with many companies involved in developing innovative drugs and biopharmaceuticals. Europe has seen the emergence of numerous biotech startups and entrepreneurial ventures focused on various aspects of the life sciences. Many of these startups require research-grade proteins for their research and development activities.
The Germany region dominated the Europe Research-grade Proteins Market, by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $163.7 Million by 2030. The UK market is exhibiting a CAGR of 14% during (2023 - 2030). Additionally, The France market would experience a CAGR of 15.8% during (2023 - 2030).
Based on Host Cell, the market is segmented into Mammalian Cells, Bacterial Cells, Yeast & Fungi, Insect Cells, and Others. Based on Product, the market is segmented into Cytokines & Growth Factors, Immune Checkpoint Proteins, Enzymes, Hormones, Antibodies, Virus Antigens, Recombinant Regulatory Proteins, and Others. Based on End-use, the market is segmented into Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., Abcam Plc, Miltenyi Biotech B.V. & Co. KG, Genscript Biotech Corporation, Bio-Techne Corporation, Proteintech Group, Inc., AcroBiosystems INC., Sino Biologicals, Inc. and ProSpec-Tany TechnoGene Ltd. and New England Biolabs, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Host Cell- Mammalian Cells
- Bacterial Cells
- Yeast & Fungi
- Insect Cells
- Others
- Cytokines & Growth Factors
- Immune Checkpoint Proteins
- Enzymes
- Hormones
- Antibodies
- Virus Antigens
- Recombinant Regulatory Proteins
- Others
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Others
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- Thermo Fisher Scientific, Inc.
- Abcam Plc
- Miltenyi Biotech B.V. & Co. KG
- Genscript Biotech Corporation
- Bio-Techne Corporation
- Proteintech Group, Inc.
- AcroBiosystems INC.
- Sino Biologicals, Inc.
- ProSpec-Tany TechnoGene Ltd.
- New England Biolabs, Inc.
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 5. Europe Research-grade Proteins Market, by Host Cell
Chapter 6. Europe Research-grade Proteins Market, by Product
Chapter 7. Europe Research-grade Proteins Market, by End-use
Chapter 8. Europe Research-grade Proteins Market, by Country
Chapter 9. Company Profiles
Companies Mentioned
- Thermo Fisher Scientific, Inc.
- Abcam Plc
- Miltenyi Biotech B.V. & Co. KG
- Genscript Biotech Corporation
- Bio-Techne Corporation
- Proteintech Group, Inc.
- AcroBiosystems INC.
- Sino Biologicals, Inc.
- ProSpec-Tany TechnoGene Ltd.
- New England Biolabs, Inc.
Methodology
LOADING...
